Citigroup’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$14K | – | 7666 |
|
|
2020
Q3 | $14K | Buy |
1,500
+200
| +15% | +$2.14K | ﹤0.01% | 6426 |
|
|
2020
Q2 | $15K | Sell |
1,300
-2,300
| -64% | -$26K | ﹤0.01% | 6833 |
|
|
2020
Q1 | $37K | Buy |
3,600
+2,100
| +140% | +$26K | ﹤0.01% | 6252 |
|
|
2019
Q4 | $25K | Buy |
1,500
+1,300
| +650% | +$19.7K | ﹤0.01% | 6823 |
|
|
2019
Q3 | $3K | Sell |
200
-800
| -80% | -$11.1K | ﹤0.01% | 7488 |
|
|
2019
Q2 | $14K | Sell |
1,000
-300
| -23% | -$4.77K | ﹤0.01% | 7211 |
|
|
2019
Q1 | $24K | Sell |
1,300
-800
| -38% | -$18.2K | ﹤0.01% | 6864 |
|
|
2018
Q4 | $55K | Sell |
2,100
-2,000
| -49% | -$47K | ﹤0.01% | 6158 |
|
|
2018
Q3 | $94K | Buy |
4,100
+2,900
| +242% | +$59.2K | ﹤0.01% | 5972 |
|
|
2018
Q2 | $23K | Sell |
1,200
-7,100
| -86% | -$119K | ﹤0.01% | 6855 |
|
|
2018
Q1 | $140K | Buy |
8,300
+2,400
| +41% | +$40.2K | ﹤0.01% | 5304 |
|
|
2017
Q4 | $90K | Sell |
5,900
-4,900
| -45% | -$72.7K | ﹤0.01% | 5736 |
|
|
2017
Q3 | $193K | Buy |
10,800
+7,300
| +209% | +$122K | ﹤0.01% | 5022 |
|
|
2017
Q2 | $57K | Sell |
3,500
-2,800
| -44% | -$40.4K | ﹤0.01% | 5700 |
|
|
2017
Q1 | $88K | Buy |
6,300
+6,100
| +3,050% | +$86.9K | ﹤0.01% | 5302 |
|
|
2016
Q4 | $3K | Sell |
200
-3,700
| -95% | -$59.5K | ﹤0.01% | 7030 |
|
|
2016
Q3 | $65K | Buy |
3,900
+3,800
| +3,800% | +$51.2K | ﹤0.01% | 5489 |
|
|
2016
Q2 | $1K | Sell |
100
-1,100
| -92% | -$10.7K | ﹤0.01% | 7001 |
|
|
2016
Q1 | $10K | Hold |
1,200
| – | – | ﹤0.01% | 6807 |
|
|
2015
Q4 | $11K | Sell |
1,200
-300
| -20% | -$2.99K | ﹤0.01% | 6788 |
|
|
2015
Q3 | $17K | Buy |
1,500
+800
| +114% | +$9.79K | ﹤0.01% | 6152 |
|
|
2015
Q2 | $9K | Buy |
+700
| New | +$7.55K | ﹤0.01% | 6525 |
|
Other funds holding VNDA
ACM
VCM
